NEU Ann: DAYBUE (trofinetide) launched in US - Neuren earns US$40m - 18th Apr 2023, 9:50am

annb0t

annb0t

Top 20
NEU Ann: DAYBUE (trofinetide) launched in US - Neuren earns US$40m
Price Sensitive: Y
Date: 18th Apr 2023, 9:50am

>>> Read announcement: Google: NEU Market Announcements
 
You must log in or register to reply here.

Similar threads

annb0t
NEU Ann: Neuren receives US$100m for expanded DAYBUE agreement - 27th Jul 2023, 11:16am
Replies
0
Views
84
annb0t
annb0t
annb0t
NEU Ann: FDA approves Daybue - the first treatment for Rett syndrome - 13th Mar 2023, 9:10am
Replies
0
Views
112
annb0t
annb0t
annb0t
NEU Ann: Q3 2023 quarterly activity and cash flow report - 20th Oct 2023, 9:30am
Replies
0
Views
66
annb0t
annb0t
annb0t
NEU Ann: Change of Director's Interest Notice - J Basile - 14th Sep 2023, 9:19am
Replies
0
Views
55
annb0t
annb0t
annb0t
NEU Ann: S&P DJI Announces September 2023 Quarterly Rebalance - 1st Sep 2023, 5:02pm
Replies
0
Views
58
annb0t
annb0t
Top Bottom